Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Apr 4;11(4):793.
doi: 10.3390/vaccines11040793.

Shoulder Pseudo-Tumor from COVID-19 Vaccine

Affiliations
Case Reports

Shoulder Pseudo-Tumor from COVID-19 Vaccine

Anas M Abbas et al. Vaccines (Basel). .

Abstract

Hypersensitivity reactions to the COVID-19 mRNA vaccines were identified in the initial 2020 trials. Appearance of a soft tissue mass is a rare manifestation of this hypersensitivity reaction. In this patient, bilateral injections resulted in the appearance of shoulder masses. Magnetic resonance imaging showed localized pseudo-tumorous edema in both shoulders, one subcutaneous and the other intramuscular. This is only the second case of a mass-like reaction to the COVID-19 vaccine mimicking a possible soft tissue neoplasm. Improper vaccination administration technique may have contributed to this complication. The case is presented to increase awareness of this potential pseudotumor.

Keywords: COVID-19; SARS-CoV-2; SIRVA; edema; education; orthopedics; shoulder; tumor; vaccine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Multiplanar MRI of right shoulder taken 8 months after vaccine administration in right shoulder. Axial T2 (A) and coronal T2 (B) images show ill-defined fluid signal surrounding interspersed areas of fat. The involved area extended from surgical neck of the humerus to distal diaphysis, measuring approximately 14.9 × 8.2 × 1.8 cm (arrows).
Figure 2
Figure 2
Multiplanar MRI of left shoulder taken 10 months after vaccine administration in left shoulder. Axial T1 weighted (A) image shows predominately intramuscular edema within the lateral deltoid muscle measuring 5.6 cm anterior-posterior and 1.0 cm medial-lateral (arrows). Coronal T1 weighted (B) image shows intramuscular edema within the lateral deltoid muscle measuring 10.0 cm proximal-distal (arrows). Axial T2 STIR (C) and coronal T1 weighted (D) images show a slightly enlarged left axillary node (9.9 × 11.2 × 12.8 mm) (arrows).

Similar articles

Cited by

References

    1. Baden L.R., El Sahly H.M., Essink B., Kotloff K., Frey S., Novak R., Diemert D., Spector S.A., Rouphael N., Creech C.B., et al. Efficacy and Safety of the MRNA-1273 SARS-CoV-2 Vaccine. N. Engl. J. Med. 2021;384:403–416. doi: 10.1056/NEJMoa2035389. - DOI - PMC - PubMed
    1. Cook I.F. Best vaccination practice and medically attended injection site events following deltoid intramuscular injection. Hum. Vaccines Immunother. 2015;5:1184–1191. doi: 10.1080/21645515.2015.1017694. - DOI - PMC - PubMed
    1. Wahl R.U., Wurpts G., Merk H.F. Impfgranulom bei Spättypallergie gegen Aluminiumsalze [Post-vaccination granulomas caused by delayed-type reaction to aluminum salts] Hautarzt. 2014;5:384–386. doi: 10.1007/s00105-014-2793-4. - DOI - PubMed
    1. Quintero D., Patel N., Harris G., Maristany A., Alani A., Rosenberg A.E., Conway S.A., Jose J. COVID-19 vaccine-associated ganulomatous mass mimicking a sarcoma: A case report. Radiol. Case Rep. 2022;17:2775–2778. doi: 10.1016/j.radcr.2022.05.035. - DOI - PMC - PubMed
    1. Nakajima Y., Mukai K., Takaoka K., Hirose T., Morishita K., Yamamoto T., Yoshida Y., Urai T., Nakatani T. Establishing a new appropriate intramuscular injection site in the deltoid muscle. Hum. Vaccines Immunother. 2017;13:2123–2129. doi: 10.1080/21645515.2017.1334747. - DOI - PMC - PubMed

Publication types

LinkOut - more resources